While CD8+ T cells mount a cytotoxic response, CD4+ T cells elicit an anti-tumor response via Th1 and Th2 type responses that produce pro-inflammatory cytokines (e.g. IFN-γ, TNF-α, and IL-4, IL-10, respectively) (371). Here, CD8A is linked to neoplasm.